Eczema Patients Have Lost Faith In Treatment: Survey

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2022-09-13 HKT 20:53

Share this story

facebook

  • Eczema patients have lost faith in treatment: survey

A international survey has found that only 37 percent of eczema patients in the city are working on treatment plans with doctors, while two-thirds have lost hope.

GlobalSkin, an international alliance of dermatology patient organisations, initiated the study covering 330 eczema patients in the SAR, South Korea and Australia in August, with one-third of the respondents in Hong Kong.

Dermatologist Dr Johnny Chan said on Tuesday that the proportion of patients in the city seeking medical advice is “very low”.

He said more than 90 percent of them are being treated by public practitioners, but strained medical resources due to the Covid-19 pandemic have delayed their treatment.

“The queue time of every [eczema] treatment will be two to three years at the moment," he said, adding that does not taken into account the impact Covid has had on waiting times even longer.

“While they are waiting, they think the treatments will not be helping them, and may lose the faith in treatment. They think it’s just incurable, they don’t want to have any treatment anymore,” Chan said.

“Public doctors have a limited time to see a lot of patients every day."

But for moderate to severe cases, he said, "they need some more time for explanations about the disease nature: to have a more tailor-made treatment plan for the patients, and to explain any possible side effects and the way to avoid these side effects.”

Chan added that less than 10 percent of eczema sufferers had sought treatment from the private sector. He said high costs was "very much an issue" here, with 72 percent of patients saying the heavy financial burden had deterred them from visiting doctors.

Dr Marco Ho, who chairs the Hong Kong Allergy Association, said when treatment is delayed, a patients’ immune system further deregulates and their conditions worsen, hence their expectations in consultations can be over-optimistic.

“Sometimes you don’t have the best-matched medication treatment as well as therapies. They have a whole lot of ideas and their own personal belief, so end up when we say ‘control’, they say ‘cure’; when we say ‘short-term gain’, they want a ‘long-term' remission,” he said.

“At times we even think the patient needs hospitalisation [but] they can't afford to stop their work or school.”

To clear up such misinterpretations and handle mental problems when patients are suffering from skin conditions, the allergy association and a concern group under the Hong Kong Health Care Alliance launched a free online counseling service on Tuesday that will run for three months.

RECENT NEWS

OCBC Plans Hong Kong Wealth Expansion With Up To 50 New Bankers

OCBC is expending its wealth management team in Hong Kong by 30% this year to meet growing regional demand for investme... Read more

Hana Financial To Acquire US$669M Stake In Dunamu, Deepening Crypto Push

Hana Financial Group has agreed to acquire a 6.55% stake in digital asset operator Dunamu. The transaction is valued at... Read more

Reap And TerraPay Partner To Expand Cross-Border Payouts Via Local Payment Rails

Reap has partnered with TerraPay to expand its cross-border payout network using domestic clearing systems. The integra... Read more

Tencent Fintech And Cloud Services Lift Q1 2026 Revenue 9% To US$8.68 Billion

Tencent reported a 9% increase in revenue from its fintech and business services division for the first quarter of 2026... Read more

Ant Group Profit Falls An Estimated 79% As AI And Payments Spending Rises

Ant Group saw an estimated 79% decline in quarterly profit as the company accelerates its spending on AI, large languag... Read more

Alibabas Cloud Revenue Jumps 40% As AI Investments Pressure Profitability

Alibaba Group has released its financial results for the quarter and fiscal year ending 31 March 2026, reporting a 3% a... Read more